Skip to main content
. 2013 Jul;57(7):3110–3120. doi: 10.1128/AAC.00267-13

Table 5.

Ratio of nanoART/native ATV and RTV by the end of the chronic-dose study on day 56 (n = 6)

Sample Ratio of nanoART/native drug
ATV RTV
Serum 4.2 13.5
Liver 12.9 270.8
Kidney 4.1 34.3
Lung 3.2 13.7
Spleen 5.7 38.4
Brain 2.1 5.1
Site of injection 7.5 27.2